Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,042 shares at $63.48 ($66K) on 2016-02-22, disclosed to the SEC on 2016-02-23.
Scheduled sale ($66k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.27 | 384 | $24K | 36.8% |
| 2 | $63.48 | 658 | $42K | 63.2% |
| Total | $63.40 avg | 1,042 | $66K | 100% |
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |